Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MEDP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMEDPMedpace$530.19-1.5%$469.47$306.70▼$628.92$15.37B1.15306,405 shs261,762 shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMEDPMedpace-1.49%-6.18%+13.45%+1.96%+63.89%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMEDPMedpace$530.19-1.5%$469.47$306.70▼$628.92$15.37B1.15306,405 shs261,762 shs10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMEDPMedpace-1.49%-6.18%+13.45%+1.96%+63.89%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMEDPMedpace 2.07Hold$469.50-11.45% DownsideCurrent Analyst Ratings BreakdownLatest MEDP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/13/2026MEDPMedpace MizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$495.00 ➝ $586.007/8/2026MEDPMedpace Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform ➝ Neutral$477.00 ➝ $547.007/7/2026MEDPMedpace Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$490.00 ➝ $515.007/2/2026MEDPMedpace Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)4/24/2026MEDPMedpace Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$522.00 ➝ $484.004/24/2026MEDPMedpace BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$500.00 ➝ $450.004/24/2026MEDPMedpace BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetMarket Perform$460.00 ➝ $400.004/24/2026MEDPMedpace Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$565.00 ➝ $477.00(Data available from 7/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMEDPMedpace$2.53B5.98$16.76 per share31.64$16.30 per share32.53Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMEDPMedpace$451.12M$15.9133.3228.602.7317.19%120.89%24.79%7/22/2026 (Confirmed)Latest MEDP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/22/2026Q2 2026MEDPMedpace$3.98N/AN/AN/A$690.66 millionN/A4/22/2026Q1 2026MEDPMedpace$3.74$4.28+$0.54$4.28$697.82 million$706.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthMEDPMedpaceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMEDPMedpaceN/A0.850.85Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMEDPMedpace77.98%Insider OwnershipCompanyInsider OwnershipMEDPMedpace20.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMEDPMedpace6,20028.56 million22.71 millionOptionableMEDP HeadlinesRecent News About These CompaniesDiversify Wealth Management LLC Purchases 3,101 Shares of Medpace Holdings, Inc. $MEDP3 hours ago | marketbeat.comWhy Medpace (MEDP) Dipped More Than Broader Market TodayJuly 13 at 7:16 PM | zacks.comMedpace (NASDAQ:MEDP) Given New $586.00 Price Target at MizuhoJuly 13 at 8:05 AM | marketbeat.comLGT Fund Management Co Ltd. Has $1.68 Million Stake in Medpace Holdings, Inc. $MEDPJuly 13 at 5:36 AM | marketbeat.com3,829 Shares in Medpace Holdings, Inc. $MEDP Bought by Hsbc Holdings PLCJuly 12 at 10:56 AM | marketbeat.comMedpace Holdings, Inc. $MEDP Shares Sold by Swedbank ABJuly 11 at 10:07 AM | marketbeat.comQRG Capital Management Inc. Sells 2,386 Shares of Medpace Holdings, Inc. $MEDPJuly 11 at 9:59 AM | marketbeat.comMedpace Holdings, Inc. $MEDP Holdings Raised by Candriam S.C.A.July 11 at 9:35 AM | marketbeat.comMedpace Holdings (MEDP) Rallies As A More Cautious Narrative Questions The ValuationJuly 11 at 6:41 AM | finance.yahoo.comMedpace (NASDAQ:MEDP) Receives Neutral Rating from Robert W. BairdJuly 9, 2026 | americanbankingnews.comMedpace Growth Trends Show How CRO Demand Is Shifting in 2026July 7, 2026 | zacks.comMedpace (NASDAQ:MEDP) Receives Hold Rating from Jefferies Financial GroupJuly 7, 2026 | americanbankingnews.comMedpace: The Recovery Narrative Looks PrematureJuly 6, 2026 | seekingalpha.comMedpace Stock Outlook Turns on Backlog Quality and CancellationsJuly 6, 2026 | zacks.comMedpace (MEDP) Ascends While Market Falls: Some Facts to NoteJuly 1, 2026 | zacks.comCON or MEDP: Which Is the Better Value Stock Right Now?June 29, 2026 | zacks.comAssenagon Asset Management S.A. Raises Stock Position in Medpace Holdings, Inc. $MEDPJune 26, 2026 | marketbeat.comMedpace (MEDP) Advances While Market Declines: Some Information for InvestorsJune 25, 2026 | zacks.comIs It Too Late to Buy Medpace Holdings Inc (MEDP) After 3.9% Rally? GF Value Says UndervaluedJune 23, 2026 | gurufocus.comWhat Makes Medpace Holdings (MEDP) an Investment Bet?June 18, 2026 | insidermonkey.comCapital Impact Advisors LLC Grows Position in Medpace Holdings, Inc. $MEDPJune 18, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMEDP Company DescriptionsMedpace NASDAQ:MEDP$530.19 -8.04 (-1.49%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$529.45 -0.74 (-0.14%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
